Delan Li
Impact in
-
- Lung Cancer Research Studies
- Drug Transport and Resistance Mechanisms
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 8
- Brain Metastases and Treatment 3
- Oncology 9
- Lung Cancer Research Studies 5
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Likun Chen (10 shared papers)Fang Wang (4 shared papers)Xue Hou (6 shared papers)Kenneth K.W. To (3 shared papers)Liwu Fu (3 shared papers)Ke Yang (2 shared papers)Qiuxiang Ou (3 shared papers)Yifan Chen (1 shared paper)
In The Last Decade
Delan Li
12 papers receiving 193 citations
Peers
Comparison fields: 5 of 32
- Oncology 134
- Pulmonary and Respiratory Medicine 118
- Cancer Research 39
- Genetics 23
- Molecular Biology 69
Countries citing papers authored by Delan Li
This map shows the geographic impact of Delan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delan Li more than expected).
Fields of papers citing papers by Delan Li
This network shows the impact of papers produced by Delan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delan Li. The network helps show where Delan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Delan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 77 | |
| 2 | 2017 | 40 | |
| 3 | 2020 | 21 | |
| 4 | 2022 | 18 | |
| 5 | 2021 | 12 | |
| 6 | 2020 | 11 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 3 | |
| 9 | 2022 | 3 | |
| 10 | 2016 | 1 | |
| 11 | 2020 | 1 | |
| 12 | 2022 | 1 | |
| 13 | 2023 | 0 |
About Delan Li
Delan Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 13 papers that have together received 195 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Cancer Genomics and Diagnostics (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Brain Metastases and Treatment (3 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Oncology (134 citations), Pulmonary and Respiratory Medicine (118 citations), Cancer Research (39 citations), Genetics (23 citations) and Molecular Biology (69 citations). Delan Li has collaborated with scholars based in China, Hong Kong and Canada. Frequent co-authors include Likun Chen, Fang Wang, Xue Hou, Kenneth K.W. To, Liwu Fu, Ke Yang, Qiuxiang Ou, Yifan Chen, Yang Shao and Xue Wu. Their work appears in journals such as Journal of Clinical Oncology, Experimental & Molecular Medicine, Cancer, Frontiers in Oncology and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.